مُلِح
سياسة·23/5/2026ملخص الذكاء الاصطناعي
Gavi offers to phase out thimerosal vaccines amid US funding dispute
An international relief group, Gavi, has offered to speed up the transition away from vaccines containing thimerosal, a mercury-based preservative, in a bid to secure $600 million in US funding. The funding has been blocked by Health Secretary Robert F. Kennedy Jr. due to his vaccine safety concerns.
P
Politico EU